2-(6-Methyl-2-azaspiro[3.3]heptan-2-yl)ethanamine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氮杂环丁烷
• 英文名称: 2-(6-Methyl-2-azaspiro[3.3]heptan-2-yl)ethanamine
• 英文别名: 2-(6-methyl-2-azaspiro[3.3]heptan-2-yl)ethanamine
• 化学式: C₉H₁₈N₂
• 分子量: 154.25
• InChiKey: BALYRMSTIYRMAR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  29.3
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• [EN] LSD1 INHIBITORS AND MEDICAL USES THEREOF<br/>[FR] INHIBITEURS DE LSD1 ET LEURS UTILISATIONS MÉDICALES
  申请人：CONSTELLATION PHARMACEUTICALS INC

  公开号：WO2018081343A1

  公开（公告）日：2018-05-03

  Provided are novel compounds of Formula (I or Ia'): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with LSD1. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I or la'), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with LSD1.

  提供了式(I或Ia')的新化合物及其药学上可接受的盐，这些化合物对治疗与LSD1相关的各种疾病、疾病或症状有用。还提供了包括式(I或Ia')的新化合物、药学上可接受的盐的药物组合物，以及治疗与LSD1相关的一种或多种疾病、疾病或症状的使用方法。
• [EN] SPIROCYCLIC MOLECULES AS MTH1 INHIBITORS<br/>[FR] MOLÉCULES SPIROCYCLIQUES SERVANT D'INHIBITEURS DE MTH1
  申请人：WANG ZHAOYIN

  公开号：WO2015172747A1

  公开（公告）日：2015-11-19

  Disclosed are spirocyclic compounds having MTH1 inhibitory activity, and methods of synthesizing and using such compounds. Preferred compounds are useful for the treatment of abnormal cell growth, such as cancers.

  揭示了具有MTH1抑制活性的螺环化合物，以及合成和使用这类化合物的方法。优选化合物可用于治疗异常细胞生长，如癌症。
• SPIROCYCLIC MOLECULES AS PROTEIN KINASE INHIBITORS
  申请人：Wang Zhaoyin

  公开号：US20140243303A1

  公开（公告）日：2014-08-28

  The present invention relates to spirocyclic compounds of formula I, namely spirocyclic (1H-pyrazol-4-yl)-3-(1-(2,6-dichloro-3-fiuorophenyl)ethoxy)pyridin-2-amines having protein kinase inhibitory activity, and methods of synthesizing and using such compounds. Preferred compounds are c-Met and/or ALK inhibitors useful for the treatment of abnormal cell growth, such as cancers. R 2 is selected from

  本发明涉及公式I的螺环化合物，即螺环(1H-吡唑-4-基)-3-(1-(2,6-二氯-3-氟苯基)乙氧基)吡啶-2-胺，具有蛋白激酶抑制活性，以及制备和使用这种化合物的方法。首选化合物是c-Met和/或ALK抑制剂，可用于治疗异常细胞生长，如癌症。R2从中选择。
• US9226923B2
  申请人：——

  公开号：US9226923B2

  公开（公告）日：2016-01-05